SU‐E‐T‐193

EPID IMRT QA for Brain, and Head‐Neck Treatment Plans in Radiation Therapy

L. Vazquez‐quino, M. Fitzpatrick, X. Chen, H. Alkhatib, P. Mavroidis, Nikos Papanikolaou

Research output: Contribution to journalArticle

Abstract

Purpose: Since amorphous‐silicon electronic portal imaging devices (EPIDs) availability the interest for radiation dosimetry use increases. In clinical quality assurance (QA) program, EPIDs has the potential to be used to verify IMRT plans in radiation therapy. The present study purpose is to test the use of an EPID phantom‐less method in clinical applications for IMRT. Methods: EPID images were acquired using a aS1000 EPID in the integrated mode, 6 MV beam, 600 MU/min dose rate (IMRT). Signal intensity of EPID images were converted to dose map using a calibrated linear signal‐dose relationship. An EPID‐based QA system was designed, which includes IMRT Quality Assurance (QA). For IMRT and VMAT QA, a phantom‐less method was proposed, which used fluence maps reconstructed from EPID‐measured fluences as input to treatment plan system for dose calculation and comparison Results: Comparison of the calculated dose using EPID‐measured fluence to the plan dose for IMRT to a point and plane dose calculated by the TPS and measured by Ion Chamber were made for 16 patient specific QA plans. The EPID‐based IMRT method was able to verify the treatment plan and capture the reasonable plan‐versus‐QA comparison with a gamma analysis (3% maximum dose, 3mm) resulting in >99 % of points with a gamma <1. EPID‐based QA dose matches well to the plan dose with similar contours. Point dose between EPID and Ion chamber measurements for IMRT plans were in average 2.24% for 16 plans including brain and Head/Neck cases. Conclusions: The results show that EPID may be properly used as a tool for clinical QA tasks and the developed EPID‐based QA system may be used for IMRT patient specific QA. Our method for EPID IMRT QA indicates the feasibility to use EPID measurements for daily patient QA verification. Potential for Conflict of Interest: Research sponsored by Oncology Data Systems, Inc, Oklahoma City, OK.

Original languageEnglish (US)
Pages (from-to)3530-3531
Number of pages2
JournalMedical Physics
Volume38
Issue number6
DOIs
StatePublished - 2011

Fingerprint

Radiotherapy
Equipment and Supplies
Brain
Therapeutics
Ions
Radiometry
Conflict of Interest
Information Systems
Neck
Head
Research

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐E‐T‐193 : EPID IMRT QA for Brain, and Head‐Neck Treatment Plans in Radiation Therapy. / Vazquez‐quino, L.; Fitzpatrick, M.; Chen, X.; Alkhatib, H.; Mavroidis, P.; Papanikolaou, Nikos.

In: Medical Physics, Vol. 38, No. 6, 2011, p. 3530-3531.

Research output: Contribution to journalArticle

Vazquez‐quino, L, Fitzpatrick, M, Chen, X, Alkhatib, H, Mavroidis, P & Papanikolaou, N 2011, 'SU‐E‐T‐193: EPID IMRT QA for Brain, and Head‐Neck Treatment Plans in Radiation Therapy', Medical Physics, vol. 38, no. 6, pp. 3530-3531. https://doi.org/10.1118/1.3612143
Vazquez‐quino, L. ; Fitzpatrick, M. ; Chen, X. ; Alkhatib, H. ; Mavroidis, P. ; Papanikolaou, Nikos. / SU‐E‐T‐193 : EPID IMRT QA for Brain, and Head‐Neck Treatment Plans in Radiation Therapy. In: Medical Physics. 2011 ; Vol. 38, No. 6. pp. 3530-3531.
@article{09d7611087744923a3be01264ab7605c,
title = "SU‐E‐T‐193: EPID IMRT QA for Brain, and Head‐Neck Treatment Plans in Radiation Therapy",
abstract = "Purpose: Since amorphous‐silicon electronic portal imaging devices (EPIDs) availability the interest for radiation dosimetry use increases. In clinical quality assurance (QA) program, EPIDs has the potential to be used to verify IMRT plans in radiation therapy. The present study purpose is to test the use of an EPID phantom‐less method in clinical applications for IMRT. Methods: EPID images were acquired using a aS1000 EPID in the integrated mode, 6 MV beam, 600 MU/min dose rate (IMRT). Signal intensity of EPID images were converted to dose map using a calibrated linear signal‐dose relationship. An EPID‐based QA system was designed, which includes IMRT Quality Assurance (QA). For IMRT and VMAT QA, a phantom‐less method was proposed, which used fluence maps reconstructed from EPID‐measured fluences as input to treatment plan system for dose calculation and comparison Results: Comparison of the calculated dose using EPID‐measured fluence to the plan dose for IMRT to a point and plane dose calculated by the TPS and measured by Ion Chamber were made for 16 patient specific QA plans. The EPID‐based IMRT method was able to verify the treatment plan and capture the reasonable plan‐versus‐QA comparison with a gamma analysis (3{\%} maximum dose, 3mm) resulting in >99 {\%} of points with a gamma <1. EPID‐based QA dose matches well to the plan dose with similar contours. Point dose between EPID and Ion chamber measurements for IMRT plans were in average 2.24{\%} for 16 plans including brain and Head/Neck cases. Conclusions: The results show that EPID may be properly used as a tool for clinical QA tasks and the developed EPID‐based QA system may be used for IMRT patient specific QA. Our method for EPID IMRT QA indicates the feasibility to use EPID measurements for daily patient QA verification. Potential for Conflict of Interest: Research sponsored by Oncology Data Systems, Inc, Oklahoma City, OK.",
author = "L. Vazquez‐quino and M. Fitzpatrick and X. Chen and H. Alkhatib and P. Mavroidis and Nikos Papanikolaou",
year = "2011",
doi = "10.1118/1.3612143",
language = "English (US)",
volume = "38",
pages = "3530--3531",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐193

T2 - EPID IMRT QA for Brain, and Head‐Neck Treatment Plans in Radiation Therapy

AU - Vazquez‐quino, L.

AU - Fitzpatrick, M.

AU - Chen, X.

AU - Alkhatib, H.

AU - Mavroidis, P.

AU - Papanikolaou, Nikos

PY - 2011

Y1 - 2011

N2 - Purpose: Since amorphous‐silicon electronic portal imaging devices (EPIDs) availability the interest for radiation dosimetry use increases. In clinical quality assurance (QA) program, EPIDs has the potential to be used to verify IMRT plans in radiation therapy. The present study purpose is to test the use of an EPID phantom‐less method in clinical applications for IMRT. Methods: EPID images were acquired using a aS1000 EPID in the integrated mode, 6 MV beam, 600 MU/min dose rate (IMRT). Signal intensity of EPID images were converted to dose map using a calibrated linear signal‐dose relationship. An EPID‐based QA system was designed, which includes IMRT Quality Assurance (QA). For IMRT and VMAT QA, a phantom‐less method was proposed, which used fluence maps reconstructed from EPID‐measured fluences as input to treatment plan system for dose calculation and comparison Results: Comparison of the calculated dose using EPID‐measured fluence to the plan dose for IMRT to a point and plane dose calculated by the TPS and measured by Ion Chamber were made for 16 patient specific QA plans. The EPID‐based IMRT method was able to verify the treatment plan and capture the reasonable plan‐versus‐QA comparison with a gamma analysis (3% maximum dose, 3mm) resulting in >99 % of points with a gamma <1. EPID‐based QA dose matches well to the plan dose with similar contours. Point dose between EPID and Ion chamber measurements for IMRT plans were in average 2.24% for 16 plans including brain and Head/Neck cases. Conclusions: The results show that EPID may be properly used as a tool for clinical QA tasks and the developed EPID‐based QA system may be used for IMRT patient specific QA. Our method for EPID IMRT QA indicates the feasibility to use EPID measurements for daily patient QA verification. Potential for Conflict of Interest: Research sponsored by Oncology Data Systems, Inc, Oklahoma City, OK.

AB - Purpose: Since amorphous‐silicon electronic portal imaging devices (EPIDs) availability the interest for radiation dosimetry use increases. In clinical quality assurance (QA) program, EPIDs has the potential to be used to verify IMRT plans in radiation therapy. The present study purpose is to test the use of an EPID phantom‐less method in clinical applications for IMRT. Methods: EPID images were acquired using a aS1000 EPID in the integrated mode, 6 MV beam, 600 MU/min dose rate (IMRT). Signal intensity of EPID images were converted to dose map using a calibrated linear signal‐dose relationship. An EPID‐based QA system was designed, which includes IMRT Quality Assurance (QA). For IMRT and VMAT QA, a phantom‐less method was proposed, which used fluence maps reconstructed from EPID‐measured fluences as input to treatment plan system for dose calculation and comparison Results: Comparison of the calculated dose using EPID‐measured fluence to the plan dose for IMRT to a point and plane dose calculated by the TPS and measured by Ion Chamber were made for 16 patient specific QA plans. The EPID‐based IMRT method was able to verify the treatment plan and capture the reasonable plan‐versus‐QA comparison with a gamma analysis (3% maximum dose, 3mm) resulting in >99 % of points with a gamma <1. EPID‐based QA dose matches well to the plan dose with similar contours. Point dose between EPID and Ion chamber measurements for IMRT plans were in average 2.24% for 16 plans including brain and Head/Neck cases. Conclusions: The results show that EPID may be properly used as a tool for clinical QA tasks and the developed EPID‐based QA system may be used for IMRT patient specific QA. Our method for EPID IMRT QA indicates the feasibility to use EPID measurements for daily patient QA verification. Potential for Conflict of Interest: Research sponsored by Oncology Data Systems, Inc, Oklahoma City, OK.

UR - http://www.scopus.com/inward/record.url?scp=85024790270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024790270&partnerID=8YFLogxK

U2 - 10.1118/1.3612143

DO - 10.1118/1.3612143

M3 - Article

VL - 38

SP - 3530

EP - 3531

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -